Mohammad AskarPublic working copy · medical review pending

Glaucoma emergencies · 203

Glaucoma emergencies: recognise closure and treat the mechanism

Recognise the emergency first, then distinguish anatomical risk from glaucoma and choose treatment for the actual mechanism.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Acute symptomatic angle closure needs immediate ophthalmic treatment. LPI addresses pupillary block; lens-related and secondary mechanisms need their own assessment.

Terminology and draft status

Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.

01Recognise and treat the acute emergency

Sudden painful red eye, blurred vision or haloes with headache, nausea or vomiting can indicate acute angle closure. A mid-dilated poorly reactive pupil, corneal oedema and a shallow peripheral anterior chamber support the diagnosis; obtain urgent ophthalmic assessment and begin treatment without delay. 1 2

Measure intraocular pressure (IOP) and confirm the angle mechanism. Pressure is often very high, but no single pressure threshold or fixed interval to irreversible damage defines safety; do not wait for a numerical cutoff or for several hours to pass. 1 2

Take a medication, allergy and systemic history while arranging urgent care. Topical aqueous suppressants, systemic acetazolamide when suitable, anti-inflammatory treatment, analgesia and antiemesis are selected under supervision; beta-blockers and alpha-agonists need their own contraindication checks. 1 2

Severe renal disease, relevant drug allergy and metabolic or electrolyte risks affect systemic treatment; mannitol requires cardiorenal and fluid assessment. 1 2

Pilocarpine is used for a pupillary-block mechanism, but may fail while the iris sphincter is ischaemic at very high IOP. EGS advises deferral at IOP ≥40 mmHg until pressure falls; this is a treatment-context threshold, not an emergency diagnostic rule. 1 2

Avoid intensive repeated dosing and do not use miotics for lens-induced or retrolenticular closure, where cycloplegia is used instead. 1 2

Laser peripheral iridotomy (LPI) relieves pupillary block by connecting the posterior and anterior chambers; it does not create a new trabecular outflow route. Perform it as soon as the cornea and patient permit. If medication does not break the attack or corneal oedema prevents LPI, specialist escalation may include iridoplasty, surgical iridectomy or cyclodiode according to the mechanism and response. 1 2

The original supine-position teaching is a proposed mechanical adjunct, not a substitute for urgent pressure control or a guarantee that the lens will move enough to relieve the block. EGS lists topical glycerin 10%, if available, to improve the view through an oedematous cornea before LPI; this selected local measure does not treat every cause of the attack and requires an appropriate preparation. 7 8

Original acetazolamide 500 mg, expressed as 2×250 mg, and the 50 mmHg IV/oral split are teaching examples, not a universal route rule or self-treatment regimen. Route and dose depend on urgency, vomiting, renal function, electrolytes, contraindications and the actual local label/protocol; Mannitol 20% likewise requires supervised cardiorenal/fluid assessment. 7 1 2

02Use the acute case to recognise urgency, not a cutoff

The original teaching case concerns a 50-year-old woman after darkness/cinema or emotional stress, with severe pain, counting-fingers vision and pressure up to 80 mmHg. Mixed injection, corneal oedema, a shallow chamber and a vertically oval mid-dilated pupil support acute closure; they are not all obligatory or a validated diagnostic score. 7 1

Examine the fellow eye and obtain the drug/surgical history. A narrow fellow angle supports shared anatomical risk, but a wide angle does not prove a secondary cause, and a narrow angle does not exclude an additional secondary mechanism. The original 75% pupillary-block estimate has no verified denominator here. 7 1

03Identify the mechanism before choosing treatment

In pupillary block, resistance at the pupil creates a pressure difference and bows the peripheral iris forward (iris bombé). The peripheral chamber is shallower than the central chamber. Relieving this component does not reverse established PAS or guarantee normal long-term outflow. 1

Anterior ciliary processes can support a plateau-iris configuration with a relatively deep central chamber and crowded peripheral angle. The double-hump sign during indentation supports this mechanism; ultrasound biomicroscopy (UBM) can show the ciliary anatomy. 1

Plateau-iris syndrome describes persistent appositional closure after a patent iridotomy has removed pupillary block. 1

A thick, anteriorly positioned, intumescent or displaced lens can crowd the angle and shallow the chamber centrally and peripherally. Lens vault measures the anterior lens surface relative to the line joining the scleral spurs. Use the full anatomy and clinical state to decide on lens surgery; a single lens-vault measurement does not prove that LPI will fail. 1

Aqueous misdirection, also called malignant glaucoma, produces forward displacement of the iris–lens diaphragm and uniform chamber shallowing, often after surgery. Exclude pupillary block and choroidal causes. 1

Cycloplegia and aqueous suppression are initial options; miotics are contraindicated. A patent iridotomy must be present, but further treatment may require laser or surgery according to lens status. 1

In selected pseudophakic eyes, zonulo-hyaloido-vitrectomy (ZHV) creates communication through the zonules, anterior hyaloid and vitreous; this explains the teaching expression “unicameral eye”. It is not a universal first operation or a guarantee against recurrence. Phakic eyes may need a posterior approach with or without lens extraction. 1

04Use gonioscopy and imaging together

Static gonioscopy documents the extent of closure; indentation tests whether the angle opens. Apposition can open with indentation, whereas established PAS remain adherent. Interpret mixed areas together rather than assigning an entire eye to a single sign. 1

Anterior-segment OCT (AS-OCT) documents angle width and lens vault without contact, but does not replace dynamic gonioscopy or reliably identify every PAS. UBM is particularly helpful for plateau iris, lens position and posterior pushing mechanisms. Use central and peripheral chamber depth as clues, then verify the cause. 1

The original terms “Volcano Sign” and “So-was-Effekt” are retained in the terminology record, but an authoritative definition and diagnostic performance remain unresolved. Describe the observed iris–lens anatomy directly. A named sign or a lens-vault cutoff should not substitute for mechanism-based assessment. 1

05Choose lens treatment for the relevant population

EAGLE randomised 419 participants aged ≥50 years without cataract to clear-lens extraction or standard LPI with medication as needed. Eligibility was newly diagnosed PAC with IOP ≥30 mmHg or PACG; advanced glaucoma and previous acute attacks were excluded. 4 5

At 36 months, extraction improved health-status score by 0.052 (95% CI 0.015–0.088) and lowered IOP by 1.18 mmHg (95% CI 0.38–1.99) relative to standard care. 4 5

This was an unmasked treatment comparison, with complete health-status data for 351 participants and IOP data for 366. The modest mean pressure difference and patient-reported benefit must be weighed against surgery, loss of accommodation and the individual target pressure. The trial does not justify clear-lens extraction for all PACS or claim that lens surgery alone cures every PACG eye. 4 5

Symptomatic cataract and lens crowding favour lens extraction, but timing follows pressure control, corneal clarity, inflammation and surgical risk. RCOphth discusses early surgery approximately 1–4 weeks after presentation in cataract-associated acute closure; EGS stresses operating when the eye is quiet. This is not a mandatory waiting interval or a universal schedule for every mechanism. 1 2

After an acute attack, shallow chamber, endothelial injury, poor dilation and zonular weakness can complicate phacoemulsification. Lens extraction widens the angle but may not restore damaged trabecular function or undo PAS. The original percentage hierarchy for acute closure, chronic PACG, pseudoexfoliation and POAG lacks a verified common comparison; do not use it as a prediction or ranking. 1

06Review secondary causes and prevent recurrence

Topiramate can cause supraciliary effusion with forward movement of the iris–lens diaphragm, often bilateral closure and an acute myopic shift. Seek urgent specialist care and coordinate rapid withdrawal with the prescriber, particularly in epilepsy. Use mechanism-directed pressure control, cycloplegia and anti-inflammatory treatment; miotics can worsen this non-pupillary mechanism, and LPI does not correct the effusion itself. 1 2 6

Uveitis, posterior synechiae with iris bombé, neovascular membranes, lens displacement and other posterior pushing causes need cause-specific care. A treatment that helps pupillary block may worsen another mechanism. Do not apply a single acute-primary algorithm to all secondary angle closure. 1 2

After the attack, reassess gonioscopy, iridotomy patency, IOP, PAS, optic nerve and visual field, then set follow-up and target pressure. The phakic fellow eye with the same anatomical risk generally needs prompt prophylactic LPI, ideally during the acute-care episode or before discharge. 1 2

Existing lens extraction, a patent iridotomy and a secondary mechanism change that decision; unilateral drug-related closure does not prove identical pupillary-block risk in the fellow eye. 1 2

Use the angle-closure guideline that actually addresses the mechanism and setting. The official DOG/BVA list labels 15a as POAG/NTG/OHT and 15b as childhood glaucoma; 15a excludes angle closure. It therefore cannot support the original attribution of a complete German acute-angle-closure algorithm or a medicolegal verdict about a missed test. 1 2 3

The original trigger list includes sulfonamides/topiramate, antihistamines, salbutamol and deep periocular Botox, plus retinal vein occlusion, silicone oil/gas and extensive PRP. These do not share a single mechanism: distinguish pupillary dilation/block from effusion, ciliary swelling, inflammation and tamponade-related displacement. Exposure alone does not establish causation; the exact Botox/ganglion pathway and source attribution remain unverified. 7 1 6

07Plan laser and rescue treatment with their limits

LPI site selection balances access, iris vessels, lid/tear-meniscus position and visual symptoms. The original 11/1 o’clock and bubble-rise explanation are technical teaching, not universal placement rules; temporal treatment is not always superior. Sequential argon pretreatment may be selected for a thick/dark iris, but a pigment/fluid cloud alone does not certify a patent, adequate iridotomy. 7 8

Paracentesis does not directly remove pupillary block. EGS permits selected refractory/no-laser use by experienced ophthalmologists, with rapid pressure relief that can wear off and risks of iris/lens injury, chamber collapse and suprachoroidal haemorrhage. RCOphth 2022 instead states no proven role and possible harm. The original yellow 30 G/no-active-aspiration narrative is preserved as unverified technique, not a general bedside needle instruction; arrange specialist escalation without delaying care. 7 8 2

Aqueous misdirection may need atropine 1% as a selected cycloplegic example, aqueous suppression and lens-status-dependent laser/operative communication. Exclude pupillary block and choroidal haemorrhage/effusion; the source word Sideritis is unresolved and is not a confirmed diagnostic label. Avoid miotics in this mechanism without calling every exposure an inevitable loss of the eye. 7 1

Plan laser and rescue treatment with their limits
MechanismFindingSelected next stepEvidence/signLimit
Pupillary blockIris bombé; posterior–anterior pressure differenceUrgent pressure control then suitable LPIVerify patency, not a pigment cloud aloneOriginal 50 mmHg rule is not a universal route/pilocarpine cutoff
Plateau irisAnterior ciliary processes; peripheral crowdingRemove coexisting block and reassess; selected iridoplastyDouble-hump/Vogel teaching sign; UBMConfiguration can be recognised before LPI; syndrome persists after patent LPI
Phacomorphic closureCrowded lens; central and peripheral shallowingLens treatment after urgent stabilisation when indicatedVolcano description; EAGLE has different selected eligibilityNo universal acute lens-removal timetable
Aqueous misdirectionUniform chamber shallowing; often postoperativeCycloplegia; selected laser/vitrectomyExclude block and choroidal causesOriginal Sideritis unresolved; avoid miotics
Drug-associated closureSome drugs cause effusion, others pupillary dilationTreat actual mechanism and coordinate culprit withdrawalOften bilateral in systemic effusionLPI treats coexisting block, not the effusion itself
What are the main learning points?

Acute symptomatic angle closure needs immediate ophthalmic treatment. LPI addresses pupillary block; lens-related and secondary mechanisms need their own assessment.

When is assessment urgent?

Sudden severe eye pain, red eye, blurred vision or haloes with nausea/vomiting require immediate eye-emergency care. Do not wait for all symptoms, press on the eye to test its hardness, or delay care to try eye drops.

References and access status

  1. 1
    EGS 6th edition, 2025 — angle closure / aqueous misdirection

    Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Selected text read: mechanisms, classification, diagnosis, PACS/PAC/PACG, acute care, post-acute surgery and aqueous misdirection, printed pp 138–149/153. Not the complete guideline or every source trial.

  2. 2
    RCOphth — Management of Angle-Closure Glaucoma, June 2022

    Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Official PDF retrieved; cover and selected acute-care text/pathway, printed pp 20–24, read as extraction. Evidence search December 2020; review due June 2025. The 2026 hosting path is not a new edition; no full-guideline or pixel inspection claimed.

  3. 3
    DOG/BVA — official guideline list and scope of 15a

    Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Official list and 15a first-page scope inspected.15a concerns POAG/NTG/OHT (2006) and excludes angle closure;15b concerns childhood glaucoma (1998). No applicable current German acute algorithm verified.

  4. 4
    Azuara-Blanco et al. — EAGLE, Lancet 2016; PMID 27707497

    Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Complete primary abstract read; main report, protocol and supplements not read. Abstract subgroup counts do not sum to the stated total; no silent reconciliation.

  5. 5
    Mitchell et al. — EAGLE secondary analysis, BJO 2023

    Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Selected primary methods and eligibility text read, including advanced-glaucoma and prior-acute-attack exclusions. Not the full analysis or supplements.

  6. 6
    DailyMed — topiramate label, section 5.1

    Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Current hosted US label section 5.1 (version 20260128) read. Not a German product label or the full prescribing information; withdrawal requires treating-team judgement.

  7. 7
    Immutable original export; own acute-angle-closure case and techniques; attribution unverified

    Complete export read; original attribution and any recording/transcript or appointment not independently verified.

  8. 8
    EGS 6,2025: selected acute paracentesis p 148 and LPI preparation p 187

    Selected locally cached EGS 6 text independently read 17 November 2026: paracentesis benefits/risks p 148 and topical glycerin 10%/LPI preparation p 187; not a new whole-guideline read or IFU.

Original lecture link